Literature DB >> 10625388

Formation of functional tissue from transplanted adrenocortical cells expressing telomerase reverse transcriptase.

M Thomas1, L Yang, P J Hornsby.   

Abstract

We report the first use of human telomerase reverse transcriptase (hTERT) expression in experimental xenotransplantation. Previously, we showed that bovine adrenocortical cells can be transplanted into severe combined immunodeficient (SCID) mice, and that these cells form functional tissue that replaces the animals' own adrenal glands. We cotransfected primary bovine adrenocortical cells with plasmids encoding hTERT, SV40 T antigen, neo, and green fluorescent protein. These clones do not undergo loss of telomeric DNA and appear to be immortalized. Two clones were transplanted beneath the kidney capsule of SCID mice. Animals that received cell transplants survived indefinitely despite adrenalectomy. The mouse glucocorticoid, corticosterone, was replaced by the bovine glucocorticoid, cortisol, in the plasma of these animals. The tissue formed from the transplanted cells resembled that formed by transplantation of cells that were not genetically modified and was similar to normal bovine adrenal cortex. The proliferation rate in tissues formed from these clones was low and there were no indications of malignant transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10625388     DOI: 10.1038/71894

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  22 in total

1.  Transplantation of adrenocortical cells.

Authors:  P J Hornsby
Journal:  Rev Endocr Metab Disord       Date:  2001-08       Impact factor: 6.514

Review 2.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 3.  Current status of gene delivery and gene therapy in lacrimal gland using viral vectors.

Authors:  Shivaram Selvam; Padmaja B Thomas; Sarah F Hamm-Alvarez; Joel E Schechter; Douglas Stevenson; Austin K Mircheff; Melvin D Trousdale
Journal:  Adv Drug Deliv Rev       Date:  2006-09-15       Impact factor: 15.470

4.  Fibroblast stimulation of blood vessel development and cancer cell invasion in a subrenal capsule xenograft model: stress-induced premature senescence does not increase effect.

Authors:  Dan Liu; Peter J Hornsby
Journal:  Neoplasia       Date:  2007-05       Impact factor: 5.715

5.  Telomerase activity coevolves with body mass not lifespan.

Authors:  Andrei Seluanov; Zhuoxun Chen; Christopher Hine; Tais H C Sasahara; Antonio A C M Ribeiro; Kenneth C Catania; Daven C Presgraves; Vera Gorbunova
Journal:  Aging Cell       Date:  2006-12-14       Impact factor: 9.304

6.  Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells.

Authors:  Michael Thomas; Tetsuya Suwa; Lianqing Yang; Lifang Zhao; Christina L Hawks; Peter J Hornsby
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

7.  Identification of a novel transcription factor binding element involved in the regulation by differentiation of the human telomerase (hTERT) promoter.

Authors:  M Tzukerman; C Shachaf; Y Ravel; I Braunstein; O Cohen-Barak; M Yalon-Hacohen; K L Skorecki
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

Review 8.  Coevolution of telomerase activity and body mass in mammals: from mice to beavers.

Authors:  Vera Gorbunova; Andrei Seluanov
Journal:  Mech Ageing Dev       Date:  2008-02-23       Impact factor: 5.432

Review 9.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 10.  New methods for investigating experimental human adrenal tumorigenesis.

Authors:  Cibele C Cardoso; Stefan R Bornstein; Peter J Hornsby
Journal:  Mol Cell Endocrinol       Date:  2008-11-13       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.